Product: Rifampin Capsules, USP, 150 mg, 30 count HDPE bottles, Rx Only, Manufactured for Lupin Pharmaceuticals, Inc., Baltimore, MD, 21202  NDC: 68180-658-06
Reason for recall: CGMP Deviations:OOS result was observed in 1-Methyl-4-Nitroso Piperazine (MNP) impurity.
Recall initiated: 20220728
Status: Terminated
Classification: Class II
Recall type: Voluntary: Firm initiated